中国快讯 (ChinaCrunch) 为中国读者提供及时的加密新闻、市场洞察和监管动态。
BioMed signs US$1.2 billion overseas antibody deal as Chinese biotech expands globally
Chinese biotechnology companies are accelerating their push into global markets, with Shanghai based Harbour BioMed announcing a partnership valued at more than US$1.2 billion to advance one of its clinical stage antibody therapies outside mainland China. The agreement underscores a broader shift in